Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a randomized, double-blind, vehicle-controlled, parallel-group comparison study to evaluate the safety and efficacy of Q301 Cream vs. vehicle in adult subjects with moderate to severe AD. Study drug (Q301 Cream or vehicle) will be administered topically twice a day for 8 consecutive weeks.
Epistemonikos ID: 6421a9a591ff2826456347d44ac21cd9bfda7937
First added on: May 12, 2024